Resection of Locally Advanced Pancreatic Cancer without Regression of Arterial Encasement After Modern-Era Neoadjuvant Therapy

被引:35
|
作者
Kluger, Michael D. [1 ]
Rashid, M. Farzan [1 ]
Rosario, Vilma L. [1 ]
Schrope, Beth A. [1 ]
Steinman, Jonathan A. [2 ]
Hecht, Elizabeth M. [2 ]
Chabot, John A. [1 ,3 ]
机构
[1] Columbia Univ, Coll Phys & Surg, Dept Surg, Div Gastrointestinal & Endocrine Surg, New York, NY USA
[2] Columbia Univ, Coll Phys & Surg, Dept Radiol, New York, NY USA
[3] New York Presbyterian Hosp, Div GI & Endocrine Surg, Columbia Coll Phys & Surg, 161 Ft Washington Ave 8th Floor, New York, NY 10032 USA
关键词
Chemotherapy; Downstaging; Neoadjuvant therapy; Pancreatic adenocarcinoma; Surgery; Irreversible electroporation; Locally advanced; IRREVERSIBLE ELECTROPORATION; ADJUVANT CHEMOTHERAPY; GEMCITABINE; SURVIVAL; ADENOCARCINOMA; CHEMORADIOTHERAPY; FOLFIRINOX; SURGERY;
D O I
10.1007/s11605-017-3556-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Modern-era systemic therapy for locally advanced pancreatic adenocarcinoma (LAPC) offers improved survival relative to historical regimens but not necessarily improved radiographic downstaging to allow more patients to undergo resection. The aim of this study was to evaluate the survival, progression, and pathologic outcomes after resection of LAPC that did not regress from > 180 degrees arterial encasement after neoadjuvant therapy. Sixty-one LAPC patients were brought to the operating room after neoadjuvant therapy for NCCN-defined unresectable pancreatic cancer between 2012 and 2017. Pts were explored with intent of pancreatectomy and irreversible electroporation for margin extension; 5 (8%) had metastatic lesions on exploratory laparoscopy and were excluded from analyses. Imaging was re-examined to confirm LAPC prior to surgery. Data were analyzed from a prospective pancreatic cancer database. Patients had arterial involvement of the celiac axis (37.5%) and/or superior mesenteric artery (42.9%) and/or an extended length of the common hepatic (n = 44.6%) artery. Twenty-nine males and 27 females, median 65 years of age, received neoadjuvant gemcitabine-based (58.9%) or FOLFIRINOX (35.7%) chemotherapy and stereotactic body (42.9%) or intensity-modulated (51.8%) radiation therapy. Median months from initiation of neoadjuvant therapy to surgery was 7.5. Sixty-one percent underwent Whipple, 21% distal, and 18% modified Appleby procedures; 57% patients underwent venous reconstruction. Ninety-day mortality was 2%. An R0 margin was achieved in 80%, and 53% were N0. Median overall and progression-free survival was 18.5 (95%CI 12.27-32.33) and 8.5 months (95%CI 6.0-15.0), respectively. One- and 3-year survival from surgery was 68.5% (95%CI 53.0-79.7) and 39.0% (95%CI 23.7-53.8), respectively. With modern-era neoadjuvant therapy, R0 resections can be achieved in a majority of non-metastatic patients with locally advanced, unresectable disease based on cross-sectional imaging.
引用
收藏
页码:235 / 241
页数:7
相关论文
共 50 条
  • [31] Distal margin distance in radical resection of locally advanced rectal cancer after neoadjuvant therapy
    Luo, Jun
    Zhu, Mingxuan
    Zhao, Long
    He, Meiwen
    Li, Bei
    Liu, Yifan
    Sun, Yuhan
    Lyu, Guoqing
    Shen, Zhanlong
    CHINESE JOURNAL OF CANCER RESEARCH, 2024, 36 (02)
  • [32] Distal margin distance in radical resection of locally advanced rectal cancer after neoadjuvant therapy
    Jun Luo
    Mingxuan Zhu
    Long Zhao
    Meiwen He
    Bei Li
    Yifan Liu
    Yuhan Sun
    Guoqing Lyu
    Zhanlong Shen
    Chinese Journal of Cancer Research, 2024, 36 (02) : 226 - 232
  • [33] Novel implications of combined arterial resection for locally advanced pancreatic cancer in the era of newer chemo-regimens
    Sonohara, Fuminori
    Yamada, Suguru
    Takami, Hideki
    Hayashi, Masamichi
    Kanda, Mitsuro
    Tanaka, Chie
    Kobayashi, Daisuke
    Nakayama, Goro
    Koike, Masahiko
    Fujiwara, Michitaka
    Fujii, Tsutomu
    Kodera, Yasuhiro
    EJSO, 2019, 45 (10): : 1895 - 1900
  • [34] Comment on "Surgery Improves Survival After Neoadjuvant Therapy for Borderline and Locally Advanced Pancreatic Cancer''
    Kirkegard, Jakob
    Mortensen, Frank Viborg
    Cronin-Fenton, Deirdre
    ANNALS OF SURGERY, 2019, 270 (06) : E138 - E139
  • [35] Clinical Efficacy of Neoadjuvant Chemoradiation Therapy for Locally Advanced Pancreatic Cancer
    Chiba, N.
    Wakabayashi, T.
    Okihara, M.
    Tomita, K.
    Takano, K.
    Shimazu, M.
    Kawachi, S.
    PANCREAS, 2014, 43 (08) : 1349 - 1349
  • [36] Pancreatectomy with major arterial resection after neoadjuvant chemoradiotherapy gemcitabine and S-1 and concurrent radiotherapy for locally advanced unresectable pancreatic cancer
    Amano, Ryosuke
    Kimura, Kenjiro
    Nakata, Bunzo
    Yamazoe, Sadaaki
    Motomura, Hisashi
    Yamamoto, Akira
    Tanaka, Sayaka
    Hirakawa, Kosei
    SURGERY, 2015, 158 (01) : 191 - 200
  • [37] Distal Pancreatectomy With En Bloc Celiac Axis Resection After Neoadjuvant Therapy for Locally Advanced Pancreatic Adenocarcinoma
    Botwinick, Isadora C.
    Schrope, Beth A.
    Chabot, John A.
    PANCREAS, 2010, 39 (07) : 1111 - 1113
  • [38] Neoadjuvant Therapy and Vascular Resection During Pancreaticoduodenectomy: Shifting the Survival Curve for Patients with Locally Advanced Pancreatic Cancer
    Epelboym, Irene
    DiNorcia, J.
    Winner, M.
    Lee, M. K.
    Lee, J. A.
    Schrope, B. A.
    Chabot, J. A.
    Allendorf, J. D.
    WORLD JOURNAL OF SURGERY, 2014, 38 (05) : 1184 - 1195
  • [39] Neoadjuvant Therapy and Vascular Resection During Pancreaticoduodenectomy: Shifting the Survival Curve for Patients With Locally Advanced Pancreatic Cancer
    DiNorcia, Joseph
    Winner, Megan
    Lee, Minna K.
    Epelboym, Irene
    Lee, James A.
    Schrope, Beth
    Chabot, John A.
    Allendorf, John D.
    GASTROENTEROLOGY, 2012, 142 (05) : S1046 - S1046
  • [40] Neoadjuvant Therapy and Vascular Resection During Pancreaticoduodenectomy: Shifting the Survival Curve for Patients with Locally Advanced Pancreatic Cancer
    Irene Epelboym
    J. DiNorcia
    M. Winner
    M. K. Lee
    J. A. Lee
    B. A. Schrope
    J. A. Chabot
    J. D. Allendorf
    World Journal of Surgery, 2014, 38 : 1184 - 1195